Literature DB >> 12499340

Lipophilic antioxidants in patients with phenylketonuria.

Catrina Colomé1, Rafael Artuch, Maria-Antònia Vilaseca, Cristina Sierra, Núria Brandi, Nilo Lambruschini, Francisco J Cambra, Jaume Campistol.   

Abstract

BACKGROUND: Low serum ubiquinone-10 concentrations have been described in phenylketonuric patients fed natural-protein-restricted diets. Such low concentrations may be related to increased free radical damage.
OBJECTIVE: We evaluated the relation between low serum ubiquinone-10 concentrations and other lipophilic antioxidants (tocopherol and retinol), selenium, glutathione peroxidase activity, and malondialdehyde concentrations as a marker of lipid peroxidation.
DESIGN: This was a cross-sectional study of 58 patients with phenylketonuria (aged 2-36 y; median: 13 y) under dietary treatment, 58 age-matched control subjects, and 30 children with moderate hyperphenylalaninemia fed unrestricted diets (aged 3-17 y; median: 7.5 y). Serum ubiquinone-10 concentrations were analyzed by HPLC with electrochemical detection. Serum retinol, serum tocopherol, and plasma malondialdehyde were analyzed by HPLC with ultraviolet detection.
RESULTS: A significant positive correlation was observed between ubiquinone-10 and tocopherol (r = 0.510, P < 0.001) in the patients with phenylketonuria. After the patients were stratified into 2 groups according to ubiquinone-10 values, significantly lower concentrations of tocopherol were observed in group 1 (low ubiquinone values) than in group 2 (normal ubiquinone values), the hyperphenylalaninemic children, and the control group. Plasma malondialdehyde concentrations were significantly higher in group 1 than in the other groups. No significant differences between groups 1 and 2 were observed in daily intakes of selenium, ascorbate, tocopherol, or retinol.
CONCLUSIONS: Plasma lipid peroxidation seems to be increased in phenylketonuria. Low concentrations of ubiquinone-10 could be associated with either excessive tocopherol consumption or high malondialdehyde concentrations in patients with phenylketonuria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12499340     DOI: 10.1093/ajcn/77.1.185

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  13 in total

Review 1.  Oxidative stress in phenylketonuria: what is the evidence?

Authors:  Graziela S Ribas; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

Review 2.  Antioxidant treatment strategies for hyperphenylalaninemia.

Authors:  Priscila Nicolao Mazzola; George Albert Karikas; Kleopatra H Schulpis; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2013-05-09       Impact factor: 3.584

Review 3.  Oxidative stress in phenylketonuria: future directions.

Authors:  Júlio César Rocha; Maria João Martins
Journal:  J Inherit Metab Dis       Date:  2011-11-25       Impact factor: 4.982

4.  Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients.

Authors:  Burcu Kumru; Davut Sinan Kaplan; Burcu Oztürk Hismi; Hakim Celik
Journal:  Cell Mol Neurobiol       Date:  2017-12-28       Impact factor: 5.046

5.  Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients.

Authors:  A Sitta; C S Vanzin; G B Biancini; V Manfredini; A B de Oliveira; C A Y Wayhs; G O S Ribas; L Giugliani; I V D Schwartz; D Bohrer; S C Garcia; M Wajner; C R Vargas
Journal:  Cell Mol Neurobiol       Date:  2010-12-30       Impact factor: 5.046

6.  Pathologic and immunohistochemical findings in hypothalamic and mesencephalic regions in the pah(enu2) mouse model for phenylketonuria.

Authors:  Jennifer E Embury; Roger R Reep; Philip J Laipis
Journal:  Pediatr Res       Date:  2005-07-31       Impact factor: 3.756

Review 7.  Oxidative stress in phenylketonuria-evidence from human studies and animal models, and possible implications for redox signaling.

Authors:  Vanessa Trindade Bortoluzzi; Carlos Severo Dutra Filho; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2021-02-13       Impact factor: 3.584

8.  A New View of Bone Loss in Phenylketonuria.

Authors:  Steven F Dobrowolski; Irina L Tourkova; Cayla R Sudano; Quitterie C Larrouture; Harry C Blair
Journal:  Organogenesis       Date:  2021-08-25       Impact factor: 2.316

9.  Profiling of oxidative stress in patients with inborn errors of metabolism.

Authors:  Peter J Mc Guire; Aditya Parikh; George A Diaz
Journal:  Mol Genet Metab       Date:  2009-06-14       Impact factor: 4.797

10.  Evidence for oxidative stress in tissues derived from succinate semialdehyde dehydrogenase-deficient mice.

Authors:  A Latini; K Scussiato; G Leipnitz; K M Gibson; M Wajner
Journal:  J Inherit Metab Dis       Date:  2007-09-21       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.